bemesetron and Acute-Disease

bemesetron has been researched along with Acute-Disease* in 1 studies

Other Studies

1 other study(ies) available for bemesetron and Acute-Disease

ArticleYear
Peripherally administered serotonin 5-HT3 receptor antagonists reduce inflammatory pain in rats.
    European journal of pharmacology, 1989, Oct-24, Volume: 170, Issue:1-2

    Intraplantar administration of serotonin 5-HT3 receptor antagonists ICS 205-930 and MDL 72222 (1-100 micrograms; 50 microliters) produced dose-related analgesia against formalin-induced acute- and Freunds adjuvant-induced chronic-inflammatory pain in rats. 5-HT3 receptor antagonists had greater effect in the chronic pain test than in the acute paradigm. In both tests, ICS 205-930 was more potent than MDL 72222. These data further support the involvement of peripheral 5-HT3 sites in inflammatory pain, and suggest the utility of selective 5-HT3 receptor antagonists as peripheral analgesics.

    Topics: Acute Disease; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Indoles; Male; Nociceptors; Pain Measurement; Rats; Serotonin Antagonists; Tropanes; Tropisetron

1989